Development of RNA Base Editing Technologies for Precision Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics.
… potential in therapeutically relevant models for targeted RNA editing presented at TIDES EU 2018 by Antti Aalto - ProQR … A-to-I modifications in endogenous RNA transcripts. This RNA editing enables e.g. the correction of G-to-A mutations, since inosines are interpreted as guanosines. RNA editing is achieved by Axiomer® Editing Oligonucleotides …
